The FDA approved Neupro (Rotigotine Transdermal System) for the treatment of Parkinson's disease and restless leg syndrome.
Jocelyn Thomas, PharmD
Advertisement
Articles by Jocelyn Thomas, PharmD
Advertisement
Latest Updated Articles
- Forest Laboratories' Viibryd
Published: August 10th 2011 | Updated:
- New FDA Actions: UCB's Neupro
Published: July 10th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Regular Melatonin Supplementation May Hide Hidden Heart Complications
2
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
3
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
4
COVID-19 During Pregnancy Raises Neurodevelopmental Risks in Children
5
